You searched for "protection"
RhinoEgypt 2026
32nd Rhino Egypt & 17th Pan-Arab Rhinology Society Meeting
Remote consultations: bringing ENT in to the 21st century
The ongoing peaks and troughs of the COVID-19 pandemic have imposed unprecedented challenges on day-to-day healthcare provision that we all took as given across the globe prior to spring 2020! The pandemic has, in many ways, made us push boundaries...
New aminoglycosides with reduced ototoxicity risk
Aminoglycoside antibiotics are widely used for infections affecting patients of all ages and at different sites, however they carry a risk of ototoxicity, nephrotoxicity and rarely peripheral neuropathy. Preventing ototoxicity is crucial to the maintenance of auditory function and quality...
Immunosuppresants and ototoxicity
There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...The Launch of the British Endoscopic Ear Group
The British Endoscopic Ear Group (BEEG) has been established to support the continued development and integration of endoscopic ear surgery (EES) within UK otological practice and training. Interest has grown steadily in recent years, driven by improved instrumentation, increasing published evidence, and a new generation of surgeons trained in both microscopic and endoscopic approaches.
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
Doing it for yourself: self-management in speech and language therapy
People with stroke aphasia are traditionally discharged from speech and language therapy when they have plateaued; meaning they are making no further progress in language recovery. This service model has been problematic, leading to people being discharged when they are...Cocaine-induced ENT pseudo-GPA (CIEpGPA): an underdiagnosed entity
Cocaine-induced ENT pseudo-GPA is increasingly seen in our ENT clinics. The authors of a new ENT UK guideline offer a concise overview for day-to-day recognition and management. Use of cocaine has steadily increased in Europe since 2010 and now represents...
Persistent dysphonia due to cricothyroid muscle dystonia – should we be requesting laryngeal EMGs for non-resolving ‘functional’ dysphonia?
This article is an interesting report of a case of persistent voice problems affecting a 43-year-old physician that significantly compromised her ability to converse and communicate at work. Specifically, she had a fluctuating voice quality that would ‘choke off’, combined...
